Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    June 2018
  1. WEI Y, Han T, Wang R, Wei J, et al
    [Corrigendum] LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6495.
    PubMed     Text format     Abstract available


    May 2018
  2. WEI Y, Han T, Wang R, Wei J, et al
    LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells.
    Oncol Rep. 2018 May 10. doi: 10.3892/or.2018.6432.
    PubMed     Text format     Abstract available


    April 2018
  3. LIN Q, Guan W, Ren W, Zhang L, et al
    MALAT1 affects ovarian cancer cell behavior and patient survival.
    Oncol Rep. 2018 Apr 19. doi: 10.3892/or.2018.6384.
    PubMed     Text format     Abstract available


  4. ZHAN SJ, Liu B, Linghu H
    Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis.
    Oncol Rep. 2018 Apr 19. doi: 10.3892/or.2018.6383.
    PubMed     Text format     Abstract available


  5. GARCIA-VAZQUEZ R, Gallardo Rincon D, Ruiz-Garcia E, Meneses Garcia A, et al
    let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6366.
    PubMed     Text format     Abstract available


  6. CHEN Z, Zhu J, Zhu Y, Wang J, et al
    MicroRNA-616 promotes the progression of ovarian cancer by targeting TIMP2.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6368.
    PubMed     Text format     Abstract available


    March 2018
  7. SONG K, Lv T, Chen Y, Diao Y, et al
    Emodin inhibits TGF-beta2 by activating the FOXD3/miR199a axis in ovarian cancer cells in vitro.
    Oncol Rep. 2018 Mar 6. doi: 10.3892/or.2018.6301.
    PubMed     Text format     Abstract available


    February 2018
  8. CUI Y, Wu F, Tian D, Wang T, et al
    miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6259.
    PubMed     Text format     Abstract available


  9. JANYST K, Janyst M, Siernicka M, Lasek W, et al
    Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells.
    Oncol Rep. 2018 Feb 6. doi: 10.3892/or.2018.6248.
    PubMed     Text format     Abstract available


  10. LIU L, Wang X, Li X, Wu X, et al
    Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
    Oncol Rep. 2018;39:818-826.
    PubMed     Text format     Abstract available


    January 2018
  11. ZHONG A, Zhang H, Xie S, Deng M, et al
    Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.
    Oncol Rep. 2018 Jan 22. doi: 10.3892/or.2018.6229.
    PubMed     Text format     Abstract available


  12. FUJIKAKE K, Kajiyama H, Yoshihara M, Nishino K, et al
    A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-beta derived from ovarian cancer.
    Oncol Rep. 2018;39:193-200.
    PubMed     Text format     Abstract available


    December 2017
  13. HU H, Huang G, Wang H, Li X, et al
    Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
    Oncol Rep. 2017 Dec 15. doi: 10.3892/or.2017.6158.
    PubMed     Text format     Abstract available


  14. ZHANG N, Qiu J, Zheng T, Zhang X, et al
    Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Oncol Rep. 2017 Dec 15. doi: 10.3892/or.2017.6159.
    PubMed     Text format     Abstract available


  15. HAO Y, Zhu L, Yan L, Liu J, et al
    c-Fos mediates alpha1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-beta1 in ovarian cancer.
    Oncol Rep. 2017;38:3355-3366.
    PubMed     Text format     Abstract available


    October 2017
  16. XIE X, Yang M, Ding Y, Yu L, et al
    Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Oncol Rep. 2017 Oct 13. doi: 10.3892/or.2017.6034.
    PubMed     Text format     Abstract available


    September 2017
  17. SU F, Geng J, Li X, Qiao C, et al
    SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumabresistant ovarian cancer model.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5998.
    PubMed     Text format     Abstract available


  18. GAO J, Zhu H, Wan H, Zou X, et al
    Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK/CREB pathway.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5952.
    PubMed     Text format     Abstract available


  19. PARK GB, Kim D
    TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
    Oncol Rep. 2017 Sep 6. doi: 10.3892/or.2017.5941.
    PubMed     Text format     Abstract available


    August 2017
  20. JIA L, Zhou J, Zhao H, Jin H, et al
    Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snailglycolysis pathways.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5886.
    PubMed     Text format     Abstract available


    July 2017
  21. ZHANG J, Liu L, Han S, Li Y, et al
    B7-H3 is related to tumor progression in ovarian cancer.
    Oncol Rep. 2017 Jul 31. doi: 10.3892/or.2017.5858.
    PubMed     Text format     Abstract available


  22. BAE JS, Lee J, Park Y, Park K, et al
    Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells.
    Oncol Rep. 2017 Jul 28. doi: 10.3892/or.2017.5853.
    PubMed     Text format     Abstract available


  23. GUO X, Guo N, Zhao J, Cai Y, et al
    Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5829.
    PubMed     Text format     Abstract available


  24. LIU N, Peng SM, Zhan GX, Yu J, et al
    Human chorionic gonadotropin beta regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Oncol Rep. 2017 Jul 14. doi: 10.3892/or.2017.5818.
    PubMed     Text format     Abstract available


  25. FENG D, Zhao T, Yan K, Liang H, et al
    Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5784.
    PubMed     Text format     Abstract available


  26. QIU S, Sun L, Jin Y, An Q, et al
    Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
    Oncol Rep. 2017;38:309-316.
    PubMed     Text format     Abstract available


    June 2017
  27. FU X, Xu L, Qi L, Tian H, et al
    BMH-21 inhibits viability and induces apoptosis by p53-dependent nucleolar stress responses in SKOV3 ovarian cancer cells.
    Oncol Rep. 2017 Jun 23. doi: 10.3892/or.2017.5750.
    PubMed     Text format     Abstract available


  28. CHEN X, Ying X, Wang X, Wu X, et al
    Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5697.
    PubMed     Text format     Abstract available


    May 2017
  29. CAO S, Chen C, Xue J, Huang Y, et al
    Silencing of type Igamma phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion.
    Oncol Rep. 2017 May 25. doi: 10.3892/or.2017.5670.
    PubMed     Text format     Abstract available


  30. SHAO G, Lai W, Wan X, Xue J, et al
    Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation.
    Oncol Rep. 2017;37:2891-2896.
    PubMed     Text format     Abstract available


  31. WINKLER I, Pyszniak M, Pogoda K, Semczuk A, et al
    Assessment of Th17 lymphocytes and cytokine IL17A in epithelial ovarian tumors.
    Oncol Rep. 2017;37:3107-3115.
    PubMed     Text format     Abstract available


  32. CHO SY, Kim K, Park MS, Jang MY, et al
    Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma.
    Oncol Rep. 2017;37:2620-2632.
    PubMed     Text format     Abstract available


    April 2017
  33. NAKAMURA K, Terai Y, Tanabe A, Ono YJ, et al
    CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5583.
    PubMed     Text format     Abstract available


  34. LIU Y, Li H, Ban Z, Nai M, et al
    Annexin A2 inhibition suppresses ovarian cancer progression via regulating beta-catenin/EMT.
    Oncol Rep. 2017 Apr 18. doi: 10.3892/or.2017.5578.
    PubMed     Text format     Abstract available


    March 2017
  35. GAO Y, Liu X, Li T, Wei L, et al
    Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
    Oncol Rep. 2017 Mar 27. doi: 10.3892/or.2017.5534.
    PubMed     Text format     Abstract available


  36. PARK GB, Chung YH, Kim D
    Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
    Oncol Rep. 2017 Mar 27. doi: 10.3892/or.2017.5533.
    PubMed     Text format     Abstract available


  37. LIU XX, Ye H, Wang P, Li LX, et al
    Proteomic-based identification of HSP70 as a tumor-associated antigen in ovarian cancer.
    Oncol Rep. 2017 Mar 24. doi: 10.3892/or.2017.5525.
    PubMed     Text format     Abstract available


  38. ZHANG Q, Chen WM, Zhang XX, Zhang HX, et al
    Overexpression of salusin-beta is associated with poor prognosis in ovarian cancer.
    Oncol Rep. 2017;37:1826-1832.
    PubMed     Text format     Abstract available


  39. YAN H, Qiu L, Xie X, Yang H, et al
    ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
    Oncol Rep. 2017;37:1412-1418.
    PubMed     Text format     Abstract available


  40. SATO M, Kawana K, Adachi K, Fujimoto A, et al
    Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
    Oncol Rep. 2017;37:1883-1888.
    PubMed     Text format     Abstract available


    January 2017
  41. GU G, Chen Y, Duan C, Zhou L, et al
    Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5388.
    PubMed     Text format     Abstract available


  42. KIM BR, Kwon Y, Rho SB
    BMI-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death.
    Oncol Rep. 2017;37:579-586.
    PubMed     Text format     Abstract available


    December 2016
  43. ZHANG H, Li W
    Dysregulation of micro-143-3p and BALBP1 contributes to the pathogenesis of the development of ovarian carcinoma.
    Oncol Rep. 2016;36:3605-3610.
    PubMed     Text format     Abstract available


    November 2016
  44. LONG Q, Yang R, Lu W, Zhu W, et al
    Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
    Oncol Rep. 2016 Nov 21. doi: 10.3892/or.2016.5263.
    PubMed     Text format     Abstract available


  45. SHEN Y, Zhang XY, Chen X, Fan LL, et al
    Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5260.
    PubMed     Text format     Abstract available


    October 2016
  46. YE J, Chen W, Wu ZY, Zhang JH, et al
    Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5198.
    PubMed     Text format     Abstract available


  47. LI J, Huang H, Li Y, Li L, et al
    Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5200.
    PubMed     Text format     Abstract available


  48. SANG XB, Sun KX, Wang LL, Chen S, et al
    Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5164.
    PubMed     Text format     Abstract available


  49. GUO P, Xiong X, Zhang S, Peng D, et al
    miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.
    Oncol Rep. 2016 Oct 3. doi: 10.3892/or.2016.5140.
    PubMed     Text format     Abstract available


    September 2016
  50. ZHU Q, Wu X, Wu Y, Wang X, et al
    Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Oncol Rep. 2016 Sep 28. doi: 10.3892/or.2016.5136.
    PubMed     Text format     Abstract available


  51. LU W, Lu T, Wei X
    Downregulation of DNMT3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response.
    Oncol Rep. 2016 Sep 28. doi: 10.3892/or.2016.5134.
    PubMed     Text format     Abstract available


  52. MENG Y, Hu J, Chen Y, Yu T, et al
    Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-kappaB and Wnt/beta-catenin pathways.
    Oncol Rep. 2016 Sep 8. doi: 10.3892/or.2016.5076.
    PubMed     Text format     Abstract available


    August 2016
  53. BI L, Yang Q, Yuan J, Miao Q, et al
    MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Oncol Rep. 2016 Aug 29. doi: 10.3892/or.2016.5055.
    PubMed     Text format     Abstract available


  54. LIN Z, Zhao J, Wang X, Zhu X, et al
    Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5012.
    PubMed     Text format     Abstract available


  55. CHEN L, Zhang F, Sheng XG, Zhang SQ, et al
    MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells.
    Oncol Rep. 2016 Aug 9. doi: 10.3892/or.2016.5010.
    PubMed     Text format     Abstract available


    July 2016
  56. GONG C, Yang Z, Wu F, Han L, et al
    miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Oncol Rep. 2016 Jul 28. doi: 10.3892/or.2016.4985.
    PubMed     Text format     Abstract available


  57. ZHU L, Guo Q, Jin S, Feng H, et al
    Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4926.
    PubMed     Text format     Abstract available


    June 2016
  58. LI L, Duan Z, Yu J, Dang HX, et al
    NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Oncol Rep. 2016 Jun 23. doi: 10.3892/or.2016.4904.
    PubMed     Text format     Abstract available


  59. MA K, Wang C, Geng Q, Fan Y, et al
    Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-kappaB signaling pathways.
    Oncol Rep. 2016;35:3505-13.
    PubMed     Text format     Abstract available


    May 2016
  60. CHE X, Yan H, Sun H, Dongol S, et al
    Grifolin induces autophagic cell death by inhibiting the Akt/mTOR/S6K pathway in human ovarian cancer cells.
    Oncol Rep. 2016 May 30. doi: 10.3892/or.2016.4840.
    PubMed     Text format     Abstract available


  61. SUNG HY, Han J, Ju W, Ahn JH, et al
    Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
    Oncol Rep. 2016 May 24. doi: 10.3892/or.2016.4835.
    PubMed     Text format     Abstract available


  62. WANG WJ, Sui H, Qi C, Li Q, et al
    Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1alpha in vitro.
    Oncol Rep. 2016 May 18. doi: 10.3892/or.2016.4813.
    PubMed     Text format     Abstract available


    April 2016
  63. ZHOU L, Xu T, Zhang Y, Zhu M, et al
    Transcriptional network in ovarian cancer cell line SKOV3 treated with Pinellia pedatisecta Schott extract.
    Oncol Rep. 2016 Apr 28. doi: 10.3892/or.2016.4779.
    PubMed     Text format     Abstract available


  64. LI Y, Wan X, Wei Y, Liu X, et al
    LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
    Oncol Rep. 2016 Apr 4. doi: 10.3892/or.2016.4729.
    PubMed     Text format     Abstract available


  65. UTSUMI F, Kajiyama H, Nakamura K, Tanaka H, et al
    Variable susceptibility of ovarian cancer cells to non-thermal plasma-activated medium.
    Oncol Rep. 2016 Apr 1. doi: 10.3892/or.2016.4726.
    PubMed     Text format     Abstract available


  66. DEVOR EJ, Schickling BM, Reyes HD, Warrier A, et al
    Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.
    Oncol Rep. 2016;35:2461-5.
    PubMed     Text format     Abstract available


  67. ELSNEROVA K, Mohelnikova-Duchonova B, Cerovska E, Ehrlichova M, et al
    Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma.
    Oncol Rep. 2016;35:2159-70.
    PubMed     Text format     Abstract available


    March 2016
  68. WANG YZ, Qiu SC
    Prediction of key genes in ovarian cancer treated with decitabine based on network strategy.
    Oncol Rep. 2016 Mar 23. doi: 10.3892/or.2016.4697.
    PubMed     Text format     Abstract available


  69. LU J, Zhang L, Xie F, Zhu L, et al
    Mild oxidative stress induced by a low dose of cisplatin contributes to the escape of TRAIL-mediated apoptosis in the ovarian cancer SKOV3 cell line.
    Oncol Rep. 2016 Mar 23. doi: 10.3892/or.2016.4702.
    PubMed     Text format     Abstract available


  70. YOSHIKAWA N, Kajiyama H, Nakamura K, Utsumi F, et al
    PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.
    Oncol Rep. 2016 Mar 3. doi: 10.3892/or.2016.4653.
    PubMed     Text format     Abstract available


  71. YANG M, Xie X, Ding Y
    SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Oncol Rep. 2016;35:1796-806.
    PubMed     Text format     Abstract available


    February 2016
  72. SU M, Chang W, Zhang K, Cui M, et al
    Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris.
    Oncol Rep. 2016;35:1179-1185.
    PubMed     Text format     Abstract available


  73. WENG Z, Gao H, Hu J, Fan Y, et al
    Isoalantolactone induces autophagic cell death in SKOV(3) human ovarian carcinoma cells via upregulation of PEA-15.
    Oncol Rep. 2016;35:833-40.
    PubMed     Text format     Abstract available


  74. TAKEDA T, Banno K, Okawa R, Yanokura M, et al
    ARID1A gene mutation in ovarian and endometrial cancers (Review).
    Oncol Rep. 2016;35:607-13.
    PubMed     Text format     Abstract available


  75. ZOU Y, Deng W, Wang F, Yu XH, et al
    A novel somatic MAPK1 mutation in primary ovarian mixed germ cell tumors.
    Oncol Rep. 2016;35:725-30.
    PubMed     Text format     Abstract available


  76. KIM BR, Lee SH, Park MS, Seo SH, et al
    MARCKSL1 exhibits anti-angiogenic effects through suppression of VEGFR-2-dependent Akt/PDK-1/mTOR phosphorylation.
    Oncol Rep. 2016;35:1041-8.
    PubMed     Text format     Abstract available


    January 2016
  77. HU C, Dong T, Li R, Lu J, et al
    Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3beta/beta-catenin/ZEB1 signaling pathway.
    Oncol Rep. 2016 Jan 25. doi: 10.3892/or.2016.4591.
    PubMed     Text format     Abstract available


  78. ZHANG R, Shi H, Ren F, Li X, et al
    Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4585.
    PubMed     Text format     Abstract available


  79. CHEN Q, Liu X, Xu L, Wang Y, et al
    Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion.
    Oncol Rep. 2016 Jan 18. doi: 10.3892/or.2016.4571.
    PubMed     Text format     Abstract available


    December 2015
  80. LI J, Li D, Zhang W
    Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
    Oncol Rep. 2015 Dec 18. doi: 10.3892/or.2015.4498.
    PubMed     Text format     Abstract available


  81. GE G, Zhang W, Niu L, Yan Y, et al
    miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
    Oncol Rep. 2015 Dec 9. doi: 10.3892/or.2015.4482.
    PubMed     Text format     Abstract available


    November 2015
  82. SHEN YF, Wei AM, Kou Q, Zhu QY, et al
    Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices.
    Oncol Rep. 2015 Nov 16. doi: 10.3892/or.2015.4423.
    PubMed     Text format     Abstract available


  83. WANG L, Niu CH, Wu S, Wu HM, et al
    PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4396.
    PubMed     Text format     Abstract available


  84. DENG Z, Zhou J, Han X, Li X, et al
    TCEB2 confers resistance to VEGFtargeted therapy in ovarian cancer.
    Oncol Rep. 2015 Nov 3. doi: 10.3892/or.2015.4388.
    PubMed     Text format     Abstract available


  85. SZCZERBA A, Sliwa A, Kubiczak M, Nowak-Markwitz E, et al
    Human chorionic gonadotropin beta subunit affects the expression of apoptosis-regulating factors in ovarian cancer.
    Oncol Rep. 2015 Nov 3. doi: 10.3892/or.2015.4386.
    PubMed     Text format     Abstract available


  86. SEINO M, Okada M, Sakaki H, Takeda H, et al
    Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4377.
    PubMed     Text format     Abstract available


  87. SU M, Fan C, Gao S, Shen A, et al
    An HCG-rich microenvironment contributes to ovarian cancer cell differentiation into endothelioid cells in a three-dimensional culture system.
    Oncol Rep. 2015;34:2395-402.
    PubMed     Text format     Abstract available


    October 2015
  88. ZHANG D, Qiu S, Wang Q, Zheng J, et al
    TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
    Oncol Rep. 2015 Oct 29. doi: 10.3892/or.2015.4356.
    PubMed     Text format     Abstract available


  89. HE Z, Chen AY, Rojanasakul Y, Rankin GO, et al
    Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1alpha/VEGF signaling pathway in ovarian cancer cells.
    Oncol Rep. 2015 Oct 27. doi: 10.3892/or.2015.4354.
    PubMed     Text format     Abstract available


  90. ZOU W, Ma X, Hua W, Chen B, et al
    Caveolin-1 mediates chemoresistance in cisplatinresistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-kappaB pathway.
    Oncol Rep. 2015 Oct 1. doi: 10.3892/or.2015.4320.
    PubMed     Text format     Abstract available


  91. GAO J, Liu M, Zou Y, Mao M, et al
    Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
    Oncol Rep. 2015 Oct 1. doi: 10.3892/or.2015.4318.
    PubMed     Text format     Abstract available


    September 2015
  92. XU Y, Wang C, Su J, Xie Q, et al
    Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
    Oncol Rep. 2015 Sep 17. doi: 10.3892/or.2015.4283.
    PubMed     Text format     Abstract available


    August 2015
  93. ZHANG J, Wang W, Qian L, Zhang Q, et al
    Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
    Oncol Rep. 2015 Aug 20. doi: 10.3892/or.2015.4213.
    PubMed     Text format     Abstract available


  94. HU L, Cong L
    Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Oncol Rep. 2015 Aug 20. doi: 10.3892/or.2015.4212.
    PubMed     Text format     Abstract available


  95. YAN S, Yuan C, Yang Q, Li X, et al
    A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.
    Oncol Rep. 2015 Aug 5. doi: 10.3892/or.2015.4179.
    PubMed     Text format     Abstract available


    July 2015
  96. SU M, Chang W, Wang D, Cui M, et al
    Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4118.
    PubMed     Text format     Abstract available


  97. WU J, Lai M, Shao C, Wang J, et al
    STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4120.
    PubMed     Text format     Abstract available


  98. ZHANG HY, Li JH, Li G, Wang SR, et al
    Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer.
    Oncol Rep. 2015 Jul 7. doi: 10.3892/or.2015.4113.
    PubMed     Text format     Abstract available


    June 2015
  99. ALTHAWADI H, Alfarsi H, Besbes S, Mirshahi S, et al
    Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.
    Oncol Rep. 2015 Jun 15. doi: 10.3892/or.2015.4061.
    PubMed     Text format     Abstract available


  100. YANG C, He X, Liu X, Tang Z, et al
    OSTP as a novel peptide specifically targeting human ovarian cancer.
    Oncol Rep. 2015 Jun 15. doi: 10.3892/or.2015.4066.
    PubMed     Text format     Abstract available


  101. DONG Y, Li J, Han F, Chen H, et al
    High IGF2 expression is associated with poor clinical outcome in human ovarian cancer.
    Oncol Rep. 2015 Jun 10. doi: 10.3892/or.2015.4048.
    PubMed     Text format     Abstract available


  102. ZHOU J, Gong G, Tan H, Dai F, et al
    Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
    Oncol Rep. 2015;33:2915-23.
    PubMed     Text format     Abstract available


  103. DONG R, Jin C, Zhang Q, Yang X, et al
    Cellular leiomyoma with necrosis and mucinous degeneration presenting as pseudo-Meigs' syndrome with elevated CA125.
    Oncol Rep. 2015;33:3033-7.
    PubMed     Text format     Abstract available


    May 2015
  104. WANG X, Jiang W, Kang J, Liu Q, et al
    Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4009.
    PubMed     Text format     Abstract available


  105. ZHAO J, Ye W, Wu J, Liu L, et al
    Sp1-CD147 positive feedback loop promotes the invasion ability of ovarian cancer.
    Oncol Rep. 2015 May 20. doi: 10.3892/or.2015.3999.
    PubMed     Text format     Abstract available


  106. MAYER S, Hirschfeld M, Jaeger M, Pies S, et al
    RON alternative splicing regulation in primary ovarian cancer.
    Oncol Rep. 2015 May 19. doi: 10.3892/or.2015.3995.
    PubMed     Text format     Abstract available


  107. HABATA S, Iwasaki M, Sugio A, Suzuki M, et al
    BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.
    Oncol Rep. 2015;33:2613-21.
    PubMed     Text format     Abstract available


    February 2015
  108. BROZYNA AA, Jozwicki W, Jochymski C, Slominski AT, et al
    Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.
    Oncol Rep. 2015;33:599-606.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: